Galectin Therapeutics Inc. (GALT)
NASDAQ: GALT · Real-Time Price · USD
3.100
+0.070 (2.31%)
At close: Mar 6, 2026, 4:00 PM EST
3.280
+0.180 (5.81%)
After-hours: Mar 6, 2026, 6:44 PM EST
Galectin Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Selling, General & Admin | 5.68 | 5.86 | 5.94 | 6.62 | 6.36 | 5.47 | |
| Research & Development | 23.47 | 36.57 | 32.13 | 31.74 | 23.82 | 17.98 | |
| Operating Expenses | 29.15 | 42.43 | 38.07 | 38.35 | 30.18 | 23.44 | |
| Operating Income | -29.15 | -42.43 | -38.07 | -38.35 | -30.18 | -23.44 | |
| Interest Expense | -7.12 | -5.54 | -2.79 | -1.03 | -0.49 | -0.09 | |
| Interest & Investment Income | 0.19 | 0.34 | 0.23 | 0.05 | 0 | 0.07 | |
| Other Non Operating Income (Expenses) | -1.23 | 0.59 | -0.43 | 0.56 | 0.14 | - | |
| EBT Excluding Unusual Items | -37.3 | -47.05 | -41.07 | -38.78 | -30.53 | -23.47 | |
| Pretax Income | -37.3 | -47.05 | -41.07 | -38.78 | -30.53 | -23.47 | |
| Net Income | -37.3 | -47.05 | -41.07 | -38.78 | -30.53 | -23.47 | |
| Preferred Dividends & Other Adjustments | 0.14 | 0.15 | 3.74 | 0.1 | 0.17 | 0.14 | |
| Net Income to Common | -37.44 | -47.2 | -44.81 | -38.87 | -30.7 | -23.6 | |
| Shares Outstanding (Basic) | 63 | 62 | 60 | 59 | 59 | 57 | |
| Shares Outstanding (Diluted) | 63 | 62 | 60 | 59 | 59 | 57 | |
| Shares Change (YoY) | 2.12% | 3.57% | 1.29% | 1.48% | 2.63% | 9.17% | |
| EPS (Basic) | -0.59 | -0.76 | -0.74 | -0.65 | -0.52 | -0.41 | |
| EPS (Diluted) | -0.59 | -0.76 | -0.74 | -0.65 | -0.52 | -0.41 | |
| EBIT | -29.15 | -42.43 | -38.07 | -38.35 | -30.18 | -23.44 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.